Home
Heart Failure Online 2022

Heart Failure Online 2022

HFO 2022 - Session 2.2 Live Case and Discussion

Ileana L Piña

1.00 EBAC

Published: 01/06/2022

Select foundational and advanced management strategies in complex patients
Discuss the validity of using ejection fraction to determine optimal treatment strategies
Assess the likely impact of health technology on future practice
Identify the underlying causes of heart failure
Select appropriate interventional and device-based treatments for treating underlying causes of heart failure
Assess the impact of the multidisciplinary team on heart failure outcomes
Discuss the importance of using quality of life and patient self-assessed measures relative to hard clinical end points

HFO 2022 - Session 1.4 Practical Theory & Hot Topics: Transitioning Care and Monitoring Technology

1.00 EBAC

Published: 01/06/2022

Select foundational and advanced management strategies in complex patients
Discuss the validity of using ejection fraction to determine optimal treatment strategies
Assess the likely impact of health technology on future practice
Identify the underlying causes of heart failure
Select appropriate interventional and device-based treatments for treating underlying causes of heart failure
Assess the impact of the multidisciplinary team on heart failure outcomes
Discuss the importance of using quality of life and patient self-assessed measures relative to hard clinical end points

HFO 2022 - Session 1.2 Practical Theory & Hot Topics: The Complex Patient

1.00 EBAC

Published: 01/06/2022

Select foundational and advanced management strategies in complex patients
Discuss the validity of using ejection fraction to determine optimal treatment strategies
Assess the likely impact of health technology on future practice
Identify the underlying causes of heart failure
Select appropriate interventional and device-based treatments for treating underlying causes of heart failure
Assess the impact of the multidisciplinary team on heart failure outcomes
Discuss the importance of using quality of life and patient self-assessed measures relative to hard clinical end points

Heart Failure Online 2022

HFO 2022 - Session 3.3: Live Case & Discussion

1.00 EBAC

Published: 01/06/2022

Select foundational and advanced management strategies in complex patients
Discuss the validity of using ejection fraction to determine optimal treatment strategies
Assess the likely impact of health technology on future practice
Identify the underlying causes of heart failure
Select appropriate interventional and device-based treatments for treating underlying causes of heart failure
Assess the impact of the multidisciplinary team on heart failure outcomes
Discuss the importance of using quality of life and patient self-assessed measures relative to hard clinical end points

Making Gains in HFpEF: An Appraisal of Where We Are Now

Shelley Zieroth Javed Butler Carolyn Lam

Not accredited

Published: 08/07/2022

Identify HFpEF patients who may benefit from being initiated on an SGLT-2 inhibitor
Recall current inertia rates amongst prescribers who manage heart failure
Adopt effective treatment strategies for HFpEF patients early in the disease course
Recall current guideline directed medical therapy options in HFpEF
Review clinical, real world and quality of life evidence for the use of SGLT-2 inhibitors in HFpEF

The 2022 ACC HF Guidelines: What Do They Mean for Your Practice?

Not accredited

Published: 09/06/2022

Summarise the main updates to the 2022 ACC heart failure (HF) guidelines
Compare updates from the ACC with the 2021 ESC HF guidelines
Recall guideline recommendations for the initiation of foundational therapy for heart failure
Adopt foundational GMDT early in the disease course
Postulate how ejection fraction will be used in future trials and in future guidelines
Review existing and forthcoming trial evidence on SGLT-2 inhibitors in HFpEF

Heart Failure Online 2022

HFO 2022 - Session 3.3: Live Case & Discussion

1.00 EBAC

Published: 01/06/2022

Select foundational and advanced management strategies in complex patients
Discuss the validity of using ejection fraction to determine optimal treatment strategies
Assess the likely impact of health technology on future practice
Identify the underlying causes of heart failure
Select appropriate interventional and device-based treatments for treating underlying causes of heart failure
Assess the impact of the multidisciplinary team on heart failure outcomes
Discuss the importance of using quality of life and patient self-assessed measures relative to hard clinical end points

The 2022 ACC HF Guidelines: What Do They Mean for Your Practice?

Not accredited

Published: 09/06/2022

Summarise the main updates to the 2022 ACC heart failure (HF) guidelines
Compare updates from the ACC with the 2021 ESC HF guidelines
Recall guideline recommendations for the initiation of foundational therapy for heart failure
Adopt foundational GMDT early in the disease course
Postulate how ejection fraction will be used in future trials and in future guidelines
Review existing and forthcoming trial evidence on SGLT-2 inhibitors in HFpEF

Making Gains in HFpEF: An Appraisal of Where We Are Now

Shelley Zieroth Javed Butler Carolyn Lam

Not accredited

Published: 08/07/2022

Identify HFpEF patients who may benefit from being initiated on an SGLT-2 inhibitor
Recall current inertia rates amongst prescribers who manage heart failure
Adopt effective treatment strategies for HFpEF patients early in the disease course
Recall current guideline directed medical therapy options in HFpEF
Review clinical, real world and quality of life evidence for the use of SGLT-2 inhibitors in HFpEF

Heart Failure Online 2022

Learning objectives

Learning objectives

Learning objectives

Heart Failure Online 2022

Learning objectives

Learning objectives

Learning objectives

Heart Failure Online 2022

Learning objectives

Learning objectives

Learning objectives